Form 8-K - Current report:
SEC Accession No. 0001437749-25-001634
Filing Date
2025-01-23
Accepted
2025-01-23 08:13:38
Documents
17
Period of Report
2025-01-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20250123_8k.htm   iXBRL 8-K 60666
2 EXHIBIT 99.1 ex_768816.htm EX-99.1 21815
3 EXHIBIT 99.2 ex_768826.htm EX-99.2 321957
8 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-25-001634.txt   576585

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nby-20250116.xsd EX-101.SCH 3401
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20250116_def.xml EX-101.DEF 11804
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20250116_lab.xml EX-101.LAB 15858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20250116_pre.xml EX-101.PRE 12019
19 EXTRACTED XBRL INSTANCE DOCUMENT nby20250123_8k_htm.xml XML 2950
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 25547679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)